In situ hybridation in undifferentiated nasopharyngeal carcinoma in tunisia. Report of 3 cases;Hybridation in situ dans les carcinomes indifférenciés du nasopharynx en tunisie. A propos de 3 observations

Tunisie Medicale

Volumn 79, Issue 10, 2001, Pages 544-547

  Nehla, Mokni Baizig ^a   Hamouda, Boussen ^a   Asma, Kharrat ^a   Farhat, Ben Ayed ^a   Abderahmen, Ladgham ^a   Omrane, Bel Haj ^b   Ahmed, El May ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

Author keywords

EBERs; In situ hybridation; LMP; Undifferentiated Carcinoma of Nasopharyngeal Type. Epstein Barr Virus; ZEBRA

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARCINOMA; CASE REPORT; EPSTEIN BARR VIRUS; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MALE; NASOPHARYNX TUMOR; PATHOGENICITY; PATHOLOGY; TUNISIA; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; CARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; MALE; NASOPHARYNGEAL NEOPLASMS; TUNISIA;

EID: 3142554622     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer : Epidemiology, Staging and Treatment. Seminars in Oncology 1994; 21: 382-397.
2. Gharbi MK, Gritli S, Boussen H, et al Epidemiologic features of 1869 cases of nasopharyngeal carcinoma (NPC) seen in the Salah Azaiz Institute from 1969 to 1987. Proceedings ASCO, abstract no431, 1996.
3. Chen CJ, Wang YF, Shieh T. Multifactorial etiology of nasopharyngeal carcinoma. Hildeshein A and Levine PH. Etiology of nasopharyngeal carcinoma : A review. Epidemiology reviews 1993; 15 :466-485.
4. Pearson GR. Epstein-Barr virus and nasopharyngeal carcinoma. J Cell Biochem 1993 17F ( suppl) : 150-154.
5. Parkin DM, Whelan SL, Ferley J, Eds. Cancer incidence in five continents. Vol VII . IARC No 143,1997.
6. Dillner J, Kallin B. The Epstein-Barr virus proteins. Adv Cancer Res 1988 ;50 :95-158.
7. Ralph F, Hopkins III, Tracy J et al. Detection of antibodies to Epstein-Barr virus antigens by Enzyme Linked Immunosorbent Assay. J Infect Diseases 1982 ;146 : 734-740.
8. Brooks L, Yao QY, Rickinson AB, et al. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells : coexpression of EBNA1, LMP1 and LMP2 transcripts. J Virol 1992 ; 66 : 2689-2697
9. James P. Stewart, John R, Arrand. Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens. Hum Pathol 1993 ; 24 :239-242.
10. Martel-Renoir D, Grunewald V, Touitou R, et al. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol. 1995 ;76 : 1401-1408.
11. Howe JG, Steitz JA. Localisation of Epstein-Barr virus -encoded small RNAs by in situ hybridation. Proc Natl Acad Sci USA 1986 :83 :90006-90010.